As of 2026-04-05, the Intrinsic Value of Sanofi SA (SAN.PA) is 53.10 EUR. This SAN.PA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 82.58 EUR, the upside of Sanofi SA is -35.70%.
The range of the Intrinsic Value is 38.49 - 78.48 EUR
Based on its market price of 82.58 EUR and our intrinsic valuation, Sanofi SA (SAN.PA) is overvalued by 35.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 38.49 - 78.48 | 53.10 | -35.7% |
| DCF (Growth 10y) | 48.42 - 89.29 | 63.48 | -23.1% |
| DCF (EBITDA 5y) | 36.92 - 47.99 | 40.57 | -50.9% |
| DCF (EBITDA 10y) | 49.48 - 65.58 | 55.53 | -32.8% |
| Fair Value | 51.51 - 51.51 | 51.51 | -37.63% |
| P/E | 89.87 - 213.44 | 144.00 | 74.4% |
| EV/EBITDA | 64.36 - 158.45 | 104.83 | 26.9% |
| EPV | 98.85 - 123.86 | 111.36 | 34.8% |
| DDM - Stable | 69.18 - 148.76 | 108.97 | 32.0% |
| DDM - Multi | 42.57 - 66.16 | 51.44 | -37.7% |
| Market Cap (mil) | 100,101.83 |
| Beta | 1.09 |
| Outstanding shares (mil) | 1,212.18 |
| Enterprise Value (mil) | 112,773.83 |
| Market risk premium | 5.82% |
| Cost of Equity | 10.33% |
| Cost of Debt | 4.25% |
| WACC | 9.17% |